These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36075788)

  • 1. Comprehensive bioinformatics analysis confirms RBMS3 as the central candidate biological target for ovarian cancer.
    Wang M; Fu X; Wang W; Zhang Y; Jiang Z; Gu Y; Chu M; Shao Y; Li S
    Med Eng Phys; 2022 Dec; 110():103883. PubMed ID: 36075788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
    Zuo L; Li X; Tan Y; Zhu H; Xiao M
    J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
    Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
    J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening the molecular targets of ovarian cancer based on bioinformatics analysis.
    Du L; Qian X; Dai C; Wang L; Huang D; Wang S; Shen X
    Tumori; 2015; 101(4):384-9. PubMed ID: 25953442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
    Xue B; Li S; Jin X; Liu L
    BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular targets of metformin against ovarian cancer based on network pharmacology.
    Guo JY; Wang YJ; Li SQ; Wu YP
    Chem Biol Drug Des; 2023 Jul; 102(1):88-100. PubMed ID: 36977503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
    Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
    J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring prognostic genes in ovarian cancer stage-related coexpression network modules.
    Yang L; Jing J; Sun L; Yue Y
    Medicine (Baltimore); 2018 Aug; 97(34):e11895. PubMed ID: 30142790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics.
    Dong C; Tian X; He F; Zhang J; Cui X; He Q; Si P; Shen Y
    J Ovarian Res; 2021 Jul; 14(1):92. PubMed ID: 34253236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Biomarkers for Ovarian Cancer Diagnosis and Prognosis by Bioinformatics Analysis and q-PCR Validation.
    Zheng Q; Ye H; Zhong H; Wang M
    Ann Clin Lab Sci; 2022 Nov; 52(6):967-975. PubMed ID: 36564071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy.
    Wei M; Bai X; Dong Q
    Transl Cancer Res; 2022 Jun; 11(6):1630-1643. PubMed ID: 35836518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatic analysis of key pathways and genes shared between endometriosis and ovarian cancer.
    Ni L; Chen Y; Yang J; Chen C
    Arch Gynecol Obstet; 2022 May; 305(5):1329-1342. PubMed ID: 34727222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 19. A comprehensive bioinformatics analysis to identify a candidate prognostic biomarker for ovarian cancer.
    Zhu H; Yue H; Xie Y; Du Q; Chen B; Zhou Y; Liu W
    Transl Cancer Res; 2021 Mar; 10(3):1537-1548. PubMed ID: 35116478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.